Amjad Masad and Haya Odeh built Replit together from scratch. Can they defend its position as an industry juggernaut?

Months of planning, a remote swamp route and a remarkable discovery helped one determined hunter turn a grueling challenge ...

As far as Dusty Crum is aware, his Florida restaurant is the only pizza place in the world that accepts invasive Burmese pythons as currency. It's his way of supporting the Florida Python Challenge, ...

The Florida Python Challenge is an annual competition to help control the invasive Burmese python population. Hunters must humanely kill captured pythons, and decapitation is not considered a humane ...

Last year’s winner was Taylor Stanberry, who removed 60 Burmese pythons in the record-breaking 2025 event Bailey Richards is a Writer-Reporter at PEOPLE. She has been working at PEOPLE since 2023 and ...

If Python developers have one consistent gripe about their beloved language, it tends to be this: Why is it so hard to take a Python program and deploy it as a standalone artifact, the way C, C++, ...

Abhinav pivoted from a career in banking to pursue his first love in writing. Even while working full-time, he continued contributing as an editor-at-large, a role he has held for more than 7 years. A ...

Replimune (REPL) has announced that it has no other option but to reduce its workforce and scale back U.S. manufacturing operations after the FDA on Friday declined to approve its lead asset, RP1, ...

In July 2025, REPL announced it had received a CRL for its biologics license application (BLA) for RP1 (vusolimogene oderparepvec) plus nivolumab in advanced melanoma patients who were PD-1 ...

Fintel reports that on November 3, 2025, BMO Capital upgraded their outlook for Replimune Group (NasdaqGS:REPL) from Underperform to Market Perform. As of October 30, 2025, the average one-year price ...

Learning Python can feel like a big task, but with the freeCodeCamp Python curriculum, it gets a lot easier. I remember when I first tried to learn Python, I bounced between tutorials, books, and ...

Fintel reports that on October 20, 2025, JP Morgan upgraded their outlook for Replimune Group (NasdaqGS:REPL) from Underweight to Neutral. As of September 30, 2025, the average one-year price target ...